Hold Rating Maintained on Edwards Lifesciences Despite Positive SAPIEN 3 Ultra RESILIA Valve Data
Analyst Josh Jennings from TD Cowen maintained a Hold rating on Edwards Lifesciences (EW – Research Report) and keeping the price target at ...
Edwards Lifesciences announces presentation of one-year SAPIEN 3 data
Edwards Lifesciences (EW) announced one-year data highlighting the continued performance of its SAPIEN 3 Ultra RESILIA valve. The data were ...
MassDevice8h
Edwards reports ‘excellent’ outcomes for Sapien 3 Ultra Resilia TAVR system
Edwards Lifesciences (NYSE:EW) today announced one-year data highlighting strong performance from its Sapien 3 Ultra Resilia ...
Edwards Lifesciences announces positive results in one year TAVI trial
Designed for patients needing a replacement valve, the company’s TAVI trial has found low rates of mortality after a year of ...
Le Lézard13h
Edwards' SAPIEN 3 Ultra RESILIA Valve Demonstrates Continued Excellent Outcomes for Patients in Real World Data
Edwards Lifesciences (NYSE: EW) today announced one-year data highlighting the continued outstanding performance of its SAPIEN 3 Ultra RESILIA valve. The data were presented at PCR London Valves 2024 ...
ETF Daily News2d
Zacks Research Analysts Reduce Earnings Estimates for EW
The company has a debt-to-equity ratio of 0.06, a quick ratio of 2.89 and a current ratio of 3.46. Edwards Lifesciences (NYSE ...
Barchart on MSN4d
Are Wall Street Analysts Predicting Edwards Lifesciences Stock Will Climb or Sink?
Edwards Lifesciences Corporation (EW), headquartered in Irvine, California, provides products and technologies for structural ...
GSA Capital Partners LLP Invests $481,000 in Edwards Lifesciences Co. (NYSE:EW)
GSA Capital Partners LLP bought a new position in shares of Edwards Lifesciences Co. (NYSE:EW – Free Report) in the third ...